Inhibrx Biosciences, Inc. (INBX)
125.12
+1.19
(+0.96%)
USD |
NASDAQ |
Aug 28, 15:10
Inhibrx Biosciences Price : 125.12 for Aug. 28, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 27, 2026 | 124.27 | 127.34 | 122.36 | 123.93 | 310883.0 |
| Aug 26, 2026 | 123.00 | 131.01 | 119.44 | 125.34 | 302858.0 |
| Aug 25, 2026 | 105.50 | 126.50 | 104.71 | 122.72 | 510619.0 |
| Aug 24, 2026 | 105.00 | 105.14 | 94.20 | 104.94 | 373620.0 |
| Aug 21, 2026 | 100.76 | 105.65 | 99.05 | 103.63 | 220745.0 |
| Aug 20, 2026 | 98.65 | 102.50 | 96.56 | 99.15 | 351489.0 |
| Aug 19, 2026 | 96.01 | 102.25 | 95.27 | 101.48 | 310658.0 |
| Aug 18, 2026 | 89.83 | 94.89 | 89.00 | 94.62 | 311231.0 |
| Aug 17, 2026 | 87.06 | 92.99 | 85.06 | 92.01 | 231742.0 |
| Aug 14, 2026 | 91.80 | 96.06 | 87.01 | 88.37 | 268290.0 |
| Aug 13, 2026 | 99.95 | 101.00 | 94.32 | 97.01 | 251198.0 |
| Aug 12, 2026 | 93.40 | 98.85 | 89.38 | 98.36 | 158559.0 |
| Aug 11, 2026 | 93.41 | 94.41 | 90.97 | 92.38 | 260026.0 |
| Aug 10, 2026 | 88.34 | 94.07 | 88.04 | 93.11 | 337144.0 |
| Aug 07, 2026 | 86.78 | 89.28 | 80.42 | 88.66 | 407686.0 |
| Aug 06, 2026 | 83.83 | 87.74 | 83.83 | 85.79 | 87655.00 |
| Aug 05, 2026 | 84.05 | 85.75 | 82.58 | 83.89 | 142141.0 |
| Aug 04, 2026 | 84.84 | 85.85 | 82.97 | 83.53 | 217684.0 |
| Aug 03, 2026 | 81.86 | 83.20 | 80.50 | 82.72 | 134530.0 |
| Jul 31, 2026 | 85.63 | 85.63 | 80.35 | 82.05 | 109089.0 |
| Jul 30, 2026 | 81.01 | 85.47 | 79.67 | 84.73 | 275503.0 |
| Jul 29, 2026 | 79.93 | 81.10 | 77.50 | 79.25 | 214199.0 |
| Jul 28, 2026 | 82.36 | 84.10 | 78.06 | 79.68 | 185902.0 |
| Jul 27, 2026 | 82.61 | 86.14 | 81.01 | 82.45 | 266031.0 |
| Jul 24, 2026 | 86.00 | 86.00 | 81.54 | 81.55 | 164939.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| AnaptysBio, Inc. | 55.83 |
| 4D Molecular Therapeutics, Inc. | 14.29 |
| Design Therapeutics, Inc. | 15.19 |
| Agenus, Inc. | 7.70 |
| Amgen, Inc. | 430.94 |
Price Related Metrics
| Earnings Yield | -7.09% |
| Market Cap | 1.840B |